Blood test could replace risky tumor biopsies for sarcoma patients
NCT ID NCT03896620
Summary
This study is testing whether a simple blood test can detect sarcoma DNA, which could help doctors diagnose and monitor the disease without needing repeated tumor biopsies. Researchers will collect blood samples from 50 sarcoma patients at different stages of treatment to look for tumor DNA markers. The goal is to find less invasive ways to track how patients respond to therapy and predict future treatment success.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Froedtert Hospital & the Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.